Inventiva S.A. (IVEVF)
OTCMKTS · Delayed Price · Currency is USD
4.440
+0.320 (7.77%)
At close: Oct 28, 2025
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.16 billion as of February 12, 2026. Its market cap has increased by 408.94% in one year.
Market Cap
1.16B
Enterprise Value
1.17B
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.44
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 142.51M to 1.16B, an increase of 715.92%. That is a compound annual growth rate of 26.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.16B | 31.41% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |